Business
Inogen to Announce Fourth Quarter and Full Year 2019 Financial Results on Tuesday, February 25, 2020
GOLETA, Calif.--(BUSINESS WIRE)-- Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare
About this update from Inogen, Inc
[{"type":"text","content":" GOLETA, Calif.--(BUSINESS WIRE)--\nInogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release fourth quarter and full year 2019 financial results after market close on Tuesday, February 25, 2020. The Company will host a corresponding conference call beginning at 1:30pm PT/4:30pm ET.\n\n\nIndividuals interested in listening to the conference call may do so by dialing (855) 238-8123 for domestic callers or (412) 317-5217 for international callers. Please reference Inogen (INGN) to join the call. To listen to a live webcast, please visit the Investor Relations section of Inogen's website at: http://investor.inogen.com/.\n\n\nA replay of the call will be available beginning February 25, 2020 at 3:30pm PT/6:30pm ET through 3:30pm PT/6:30pm ET on March 3, 2020. To access the replay, dial (877) 344-7529 or (412) 317-0088 and reference Access Code: 10138970. The webcast will also be available on Inogen's website for one year following the completion of the call.\n\n\nInogen has used, and intends to continue to use, its Investor Relations website, http://investor.inogen.com/, as a means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD. For more information, visit http://investor.inogen.com/.\n\n\nAbout Inogen\n\n\nInogen is innovation in oxygen therapy. We are a medical technology company that develops, manufactures and markets innovative oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.\n\n\nFor more information, please visit www.inogen.com.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20200128005277/en/\n\nInvestor Relations Contact:\nMatt Bacso, CFA\n805-879-8205\n\n\nMedia Contact:\nByron Myers\n805-562-0503\n\nSource: Inogen, Inc.","length":4463,"tagName":"div"}]